CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates the risks associated with discontinuing antidepressants during pregnancy. It aims to identify factors that influence relapse rates, combining demographic, clinical, and genetic data to provide personalized treatment recommendations for pregnant women.
Antidepressants are the mainstay of pharmacological treatment for depressive and anxiety disorders in the perinatal period, and up to one in ten pregnant women take them.
Among these women, over 50% discontinue antidepressants during pregnancy due to fear of possible adverse fetal effects.
However, discontinuation may increase the risk of relapse, which can also have profound negative impacts.
Evidence on perinatal relapse risk following antidepressant discontinuation during pregnancy is sparse…
AARHUS UNIVERSITET
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Australia, Brisbane
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
